UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
10.64
-0.07 (-0.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
UroGen Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 449 | 463 | 205 | 213 | 398 | 700 | |
| Market Cap Growth | 23.92% | 126.06% | -3.94% | -46.44% | -43.13% | 0.97% | |
| Enterprise Value | 318 | 409 | 184 | 105 | 276 | 481 | |
| Last Close Price | 10.64 | 15.00 | 8.87 | 9.51 | 18.02 | 33.37 | |
| PS Ratio | 4.45 | 5.60 | 3.18 | 4.44 | 33.74 | 38893.81 | |
| PB Ratio | 17.59 | -7.10 | -2.29 | 25.34 | 4.13 | 3.88 | |
| P/TBV Ratio | 20.96 | - | - | 25.34 | 4.13 | 3.88 | |
| EV/Sales Ratio | 3.55 | 4.95 | 2.85 | 2.18 | 23.36 | 26736.92 | |
| Debt / Equity Ratio | 4.81 | -1.54 | -1.12 | 0.18 | 0.03 | 0.02 | |
| Asset Turnover | 0.36 | 0.53 | 0.50 | 0.40 | 0.07 | 0.00 | |
| Inventory Turnover | 1.38 | 1.87 | 1.67 | 1.52 | - | - | |
| Quick Ratio | 8.31 | 4.88 | 4.71 | 4.51 | 5.09 | 7.55 | |
| Current Ratio | 9.00 | 5.42 | 5.39 | 5.11 | 5.39 | 7.63 | |
| Return on Equity (ROE) | - | - | - | -211.55% | -92.88% | -77.77% | |
| Return on Assets (ROA) | -21.12% | -26.09% | -38.69% | -47.72% | -46.29% | -44.73% | |
| Return on Capital (ROIC) | -50.64% | -179.24% | -479.55% | -105.88% | -52.96% | -49.84% | |
| Earnings Yield | -25.70% | -22.08% | -53.60% | -51.98% | -32.27% | -15.02% | |
| FCF Yield | -21.47% | -16.54% | -42.88% | -40.17% | -26.90% | -10.19% | |
| Buyback Yield / Dilution | -46.48% | -26.43% | -2.06% | -2.60% | -6.10% | -30.31% | |
| Total Shareholder Return | -46.48% | -26.43% | -2.06% | -2.60% | -6.10% | -30.31% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.